Creative Planning Decreases Stock Position in Bath & Body Works, Inc. (NYSE:BBWI)

Creative Planning lowered its stake in Bath & Body Works, Inc. (NYSE:BBWI) by 9.1% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 15,139 shares of the company’s stock after selling 1,509 shares during the quarter. Creative Planning’s holdings in Bath & Body Works were worth $483,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of the stock. Vanguard Group Inc. lifted its stake in Bath & Body Works by 4.2% in the 1st quarter. Vanguard Group Inc. now owns 27,398,192 shares of the company’s stock worth $1,370,458,000 after purchasing an additional 1,102,124 shares in the last quarter. Lone Pine Capital LLC raised its position in shares of Bath & Body Works by 15.8% during the 2nd quarter. Lone Pine Capital LLC now owns 11,315,515 shares of the company’s stock valued at $441,871,000 after buying an additional 1,547,399 shares in the last quarter. Anomaly Capital Management LP purchased a new stake in shares of Bath & Body Works during the 2nd quarter valued at about $113,995,000. Sound Shore Management Inc. CT raised its position in shares of Bath & Body Works by 10.0% during the 2nd quarter. Sound Shore Management Inc. CT now owns 2,088,703 shares of the company’s stock valued at $81,564,000 after buying an additional 189,889 shares in the last quarter. Finally, Bessemer Group Inc. raised its position in shares of Bath & Body Works by 5.6% during the 1st quarter. Bessemer Group Inc. now owns 1,448,278 shares of the company’s stock valued at $72,443,000 after buying an additional 76,183 shares in the last quarter. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Insider Activity

In other Bath & Body Works news, CEO Gina Boswell acquired 6,000 shares of the company’s stock in a transaction dated Wednesday, October 9th. The shares were purchased at an average cost of $29.64 per share, for a total transaction of $177,840.00. Following the completion of the purchase, the chief executive officer now owns 242,987 shares in the company, valued at approximately $7,202,134.68. This trade represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders own 0.27% of the company’s stock.

Bath & Body Works Price Performance

Shares of BBWI stock opened at $31.73 on Thursday. The company has a market capitalization of $6.95 billion, a P/E ratio of 7.68, a P/E/G ratio of 0.99 and a beta of 1.79. The company’s 50-day simple moving average is $30.02 and its two-hundred day simple moving average is $37.16. Bath & Body Works, Inc. has a one year low of $26.20 and a one year high of $52.99.

Bath & Body Works (NYSE:BBWI) last issued its earnings results on Wednesday, August 28th. The company reported $0.37 EPS for the quarter, topping analysts’ consensus estimates of $0.35 by $0.02. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. The business had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.54 billion. On average, research analysts expect that Bath & Body Works, Inc. will post 3.18 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 6th. Stockholders of record on Friday, August 23rd were paid a dividend of $0.20 per share. The ex-dividend date was Friday, August 23rd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.52%. Bath & Body Works’s dividend payout ratio is presently 19.37%.

Wall Street Analysts Forecast Growth

BBWI has been the topic of several recent research reports. Piper Sandler decreased their target price on shares of Bath & Body Works from $47.00 to $39.00 and set a “neutral” rating on the stock in a research report on Thursday, July 11th. UBS Group decreased their target price on shares of Bath & Body Works from $52.00 to $38.00 and set a “neutral” rating on the stock in a research report on Thursday, August 29th. Barclays decreased their target price on shares of Bath & Body Works from $32.00 to $31.00 and set an “equal weight” rating on the stock in a research report on Thursday, August 29th. JPMorgan Chase & Co. decreased their target price on shares of Bath & Body Works from $42.00 to $39.00 and set a “neutral” rating on the stock in a research report on Thursday, August 29th. Finally, Wells Fargo & Company cut their price target on shares of Bath & Body Works from $35.00 to $32.00 and set an “equal weight” rating on the stock in a report on Wednesday. Seven research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $42.63.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.